Trials / Completed
CompletedNCT01051258
AeriSeal System for Lung Volume Reduction
A Study of the AeriSeal System for Lung Volume Reduction in Patients With Advanced Emphysema
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Aeris Therapeutics · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of AeriSeal treatment in patients with advanced emphysema.
Detailed description
The purpose of this study is to evaluate the safety and efficacy of AeriSeal treatment in patients with advanced homogeneous and heterogeneous emphysema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AeriSeal System | AeriSeal System for Lung Volume Reduction |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2011-08-01
- Completion
- 2013-04-01
- First posted
- 2010-01-18
- Last updated
- 2013-06-26
Locations
8 sites across 4 countries: Austria, France, Germany, Israel
Source: ClinicalTrials.gov record NCT01051258. Inclusion in this directory is not an endorsement.